Clobetasol reduces vulvar malignancy risk at 2 years after diagnosis; topical calcineurin inhibitors do not increase ...

ABSTRACT: Background: Propensity score methods have become a cornerstone of modern causal inference, enabling researchers to approximate the conditions of randomized experiments in observational ...

ABSTRACT: Background: Propensity score methods have become a cornerstone of modern causal inference, enabling researchers to approximate the conditions of randomized experiments in observational ...

The holidays are a magical time, filled with sparkling lights, the smell of pine, and, most importantly, the warmth of family memories. But let’s be honest: the best memories often happen not in the ...

Patients who received neoadjuvant systemic therapy followed by surgical resection for mucosal HNSCC in the US National Cancer Database (2004-2022) were evaluated using 1:5 propensity score matching to ...

Early stroke recurrence is a significant risk for survivors of ischemic stroke. Although admission severity is commonly used in prognosis, the predictive value of residual neurological deficits at ...

There are 198 games scheduled across Wisconsin on Friday, October 10, including 20 games featuring statewide top 25 ranked teams. You can follow every game live on ourWisconsin High School Football ...

Objective Patients with non-ST segment elevation acute coronary syndrome (NSTEACS) admitted into emergency department are usually combined with a high number of comorbidities. Charlson Comorbidity ...

A panelist discusses how a large propensity score–matched analysis of 1300 patients aged 60-75 found similar all-cause mortality between intensive chemotherapy and azacitidine plus venetoclax, but ...

The albumin-to-alkaline phosphatase ratio (AAPR) has recently emerged as a novel prognostic biomarker in various solid tumors. However, its clinical value in lower-grade glioma (LGG) remains unclear.

Darolutamide plus androgen-deprivation therapy (ADT) with docetaxel is one of the standards of care for metastatic hormone-sensitive prostate cancer (mHSPC), based on the phase III ARASENS study. To ...